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Results: Of 152,762 reports to STIC, 55 involved OD with thiopu-
rines (n = 39), MMF (n = 14), or SIR (n = 2). Of these, 32 were with 
suicidal intent, 19 accidental, and 4 iatrogenic errors. Eleven (31%) 
thiopurine, 4 (31%) MMF, and 1 (50%) SIR ODs had attributable 
symptoms. The majority of symptoms were minor, although 1 case 
of sustained thiopurine OD caused agranulocytosis, 1 case of a 9-fold 
MMF OD caused biphasic hypotension (possibly reflecting entero-
hepatic circulation), and 1 case of SIR OD in a child caused tremor, 
raised liver enzymes, and gastroenteritis. Symptoms were observed 
in patients taking 1.5 and 2.4 times or greater than their usual dose 
(or the maximum licensed dose in patients not usually taking medica-
tion) for thiopurines and MMF, respectively. Decontamination meas-
ures were undertaken in 10 thiopurine ODs (9 activated charcoal, 
1 gastric lavage). The OR for the development of symptoms after 
gastrointestinal decontamination in these ODs was 0.14 (95% CI, 
0.01–1.5) compared with cases without decontamination. Charcoal 
was given primarily to children. The mean age of cases managed 
with charcoal was 8 (10) versus 30 (15) years for cases managed 
without (P < 0.0001).
Conclusion: Acute toxicity with thiopurines appears to only be 
significant with a prolonged exposure to high drug concentrations. 
MMF ODs seem to be well tolerated. Physicians should be aware, 
however, that patients who develop hypotension shortly after oral 
OD may relapse some hours later. It seems that SIR is highly toxic in 
young children even at modest degrees of overdose. Gastrointestinal 
decontamination with activated charcoal appeared to reduce symp-
tom development after overdose of thiopurines. Thiopurine, MMF, 
and SIR OD patterns, outcomes, and management require contin-
ued study and transplant and poisons centers should be encouraged 
to actively seek follow-up data on the cases with which they are 
involved.
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Introduction: Pipamperone (PIP) is a mild to moderately potent buty-
rophenone neuroleptic. Its mechanism of action is thought to be the 
antagonism of serotonin 5-HT2A and dopamine D4 receptors. The 
aim of the study was to analyze the clinical features of PIP poison-
ing because information on patterns of toxicity of this substance in 
overdose is scarce and limited to case reports.
Patients (or Materials) and Methods: Retrospective consecutive 
review of acute PIP monointoxications reported by physicians to the 
STIC between August 1974 and November 2012.
Results: Thirty-two adults, 3 teenagers, and 3 children could be 
included. Mean age of the group with adults and teenagers was 41 
years (range, 14–90), and the ingested dose in this group ranged 
between 60 and 2400 mg (mean, 638). Five (14%) patients remained 
asymptomatic, 21 (60%) showed minor, 8 (22%) moderate, and 1 
severe symptoms according to Poisoning Severity Score. There was 
no fatality. Minor symptoms occurred after ingestion of 60 to 1200 
mg PIP (mean, 578), moderate symptoms after 160 to 2400 mg 
(mean, 950), and severe symptoms after 1200 mg. Signs and symp-
toms predominantly involved the central nervous and the cardiovas-
cular systems (Table). An ECG was available in 20 patients, and 
8 showed a prolonged QTc interval (455–505 ms) after ingestion of 
400 to 1600 mg. A previously healthy woman developed a general-
ized seizure after ingestion of 1600 mg. Coma occurred after intake 
of 1200 mg in an adult, and 360 mg in a 4.5-year-old child. Two 
children (2- and 4-year-old) remained asymptomatic after ingestion 
of 10 and 80 mg, respectively.
Conclusion: The severity of poisoning was related to the ingested 
PIP dose. Overdose was associated mostly with mild to moderate, 
neurologic and cardiovascular signs/symptoms. There was 1 acute 
single convulsive episode, which has not been previously described in 
literature. The remarkable frequency of QTc prolongation deserves 
particular attention, since a case of torsades de pointes has been pre-
viously described.1 The relevance of this phenomenon could increase 
in the near future because a fixed combination of low-dose PIP and 
citalopram, which has also QT prolonging potential, is investigated 
in a Phase III study. Poisoned patients should be monitored for central 
nervous system depression, dysrhythmias and QTc prolongation.
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Introduction: Inhabitants of Melun and vicinities have been exposed 
to a waste incinerator (1974–2002) emitting high concentrations of 
dioxins (226 ng I-TEQ/Nm3) up to 2000-times the maximal recom-
mended values. This constitutes a case of unique and well-identified 
source of pollution. Dioxin (TCDD) is a well-described CYP1A 
inducer in vitro but in vivo studies are, however, rare. CYP1A has 
a role in the activation of some environmental and food-borne car-
cinogens and metabolic ratio of paraxanthine (17X) and caffeine 
(1,3,7-trimethylxanthine, 137X) is used as a measure of its activity. 
The aim of the study was to assess the exposed population through 
Table.  Symptoms/signs with classification according to severity 
(Poisoning Severity Score).
Severity
Symptom/Sign Minor n (%) Moderate n (%) Severe n (%)
Somnolence 15 (39)
Coma 2 (5.2) 2 (5.2)
Dystonic reactions 3 (7.9) 1 (2.6)
Seizures 1 (2.6)
Disorientation 1 (2.6)
Agitation 1 (2.6) 1 (2.6)
Tachycardia 6 (15.8)
Hypotension 5 (13.1) 1 (2.6)
QTc prolongation 8 (18.4) 1 (2.6)
AV block I 1 (2.6)
Xerostomia 3 (7.9)
Gastrointestinal symptoms 3 (7.9)
Urinary retention 1 (2.6)
